← Evidence map

ArticleEMBO molecular medicine2024

Publisher Correction: Novel immunotherapeutics against LGR5 to target multiple cancer types.

Hung-Chang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39322863